Superficial (early) endocervical adenocarcinoma in situ: A study of 12 cases and comparison to conventional AIS

American Journal of Surgical Pathology

Volumn 29, Issue 12, 2005, Pages 1609-1614

  Witkiewicz, Agnieszka ^a   Lee, Kenneth R ^a   Brodsky, Gilbert ^a   Cviko, Aida ^a   Brodsky, Joshua ^a   Crum, Christopher P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Adenocarcinoma in situ; Cervical neoplasms; HPV; In situ hybridization; INFORM HPV; Ki 67; p16ink4

Indexed keywords

BIOLOGICAL MARKER; DNA; KI 67 ANTIGEN; NUCLEIC ACID; PROTEIN P16INK4A; VIRUS DNA; TUMOR MARKER;

ADENOCARCINOMA; ADOLESCENT; ADULT; ARTICLE; CARCINOMA IN SITU; CELL NUCLEUS; COMORBIDITY; CONTROLLED STUDY; DNA HYBRIDIZATION; ENDOCERVICAL ADENOCARCINOMA IN SITU; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MITOSIS; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CONIZATION; APOPTOSIS; BIOPSY; CASE REPORT; COMPARATIVE STUDY; DNA PROBE; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; PAPILLOMA VIRUS; PATHOLOGY; RETROSPECTIVE STUDY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VIROLOGY;

ADENOCARCINOMA; ADOLESCENT; ADULT; APOPTOSIS; BIOPSY; CARCINOMA IN SITU; CELL NUCLEUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; CONIZATION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA PROBES, HPV; DNA, NEOPLASM; DNA, VIRAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KI-67 ANTIGEN; MITOSIS; PAPILLOMAVIRIDAE; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 33644791454     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000173239.24955.a2     Document Type: Article

References (12)

1. Cooper K, Herrington CS, Lo ES, et al. Integration of human papillomavirus types 16 and 18 in cervical adenocarcinoma. J Clin Pathol. 1992;45:382-384.
2. Keating JT, Cviko A, Riethdorf S, et al. Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol. 2001;25:884-891.
3. Lee KR. Symposium part 4: Should pathologists diagnose endocervical preneoplastic lesions "less than" adenocarcinoma in situ? [Counterpoint]. Int J Gynecol Pathol. 2003;22:22-24.
4. Lee KR, Rose PG. Glandular lesions of the cervix. In: Crum CP, Lee KR, eds. Diagnostic Gynecologic and Obstetric Pathology. Philadelphia: Saunders, in press.
5. Lee KR, Sun D, Crum CP. Endocervical intraepithelial glandular atypia (dysplasia): a histopathologic, human papillomavirus, and MIB-1 analysis of 25 cases. Hum Pathol. 2000;31:656-664.
6. Montes MA, Cibas ES, DiNisco SA, et al. Cytologic characteristics of abnormal cells in prior 'normal' cervical/vaginal Papanicolaou smears from women with a high grade squamous intraepithelial lesion. Cancer. 1999;87:56-59.
7. Park JJ, Sun D, Quade BJ, et al. Stratified mucin-producing intraepithelial lesions of the cervix: adenosquamous or columnar cell neoplasia? Am J Surg Pathol. 2000;24:1414-1419.
8. Renshaw AA, Bellerose B, DiNisco SA, et al. False negative rate of cervical cytologic smear screening as determined by rapid rescreening. Acta Cytol. 1999;43:344-350.
9. Riethdorf L, Riethdorf S, Lee KR, et al. Human papillomaviruses, expression of p16, and early endocervical glandular neoplasia. Hum Pathol. 2002;33:899-904.
10. Ruba S, Schoolland M, Allpress S, et al. Adenocarcinoma in situ of the uterine cervix: screening and diagnostic errors in Papanicolaou smears. Cancer. 2004;102:280-287.
11. Witkiewicz AK, Hecht JL, Cviko A, et al. Microglandular hyperplasia: a model for the de novo emergence and evolution of endocervical reserve cells. Hum Pathol. 2005;36:154-161.
12. Zaino RJ. Symposium part I: Adenocarcinoma in situ, glandular dysplasia, and early invasive adenocarcinoma of the uterine cervix. Int J Gynecol Pathol. 2002;21:314-326.